Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207883979> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3207883979 endingPage "S28" @default.
- W3207883979 startingPage "S27" @default.
- W3207883979 abstract "BACKGROUND Certain congenital heart diseases (CHDs) are associated with a high risk of intrauterine fetal demise (IUFD) and post-natal death, including Ebstein's anomaly, tetralogy of Fallot with absent pulmonary valve and cardiomyopathy. Established obstetric guidelines that recommend frequent antenatal surveillance (AS) of fetal wellbeing in the case of specific maternal and fetal risk factors do not currently include fetuses with high-risk CHD. We sought to establish whether frequent antenatal surveillance could improve fetal outcomes in high-risk fetal CHD and if surveillance results are predictive of outcomes in this setting. We hypothesized that fetuses with high-risk cardiac lesions would benefit from frequent AS and that outcomes would be poorer where surveillance results were abnormal. METHODS AND RESULTS We undertook a single center, retrospective review of 61 pregnancies with high-risk fetal CHD diagnosed from 2006-2020. Data pertaining to frequency and results of AS were collected. AS was conducted using the biophysical profile score, non-stress testing and/or fetal echocardiogram. Where possible, the cardiovascular profile score (CVPS) was calculated retrospectively. Frequent surveillance was defined as at least weekly fetal wellbeing testing commencing by 28-32 weeks gestation, or from later diagnosis, until delivery. Outcome measures included survival and mode of delivery. Chi-square testing, or Fisher's exact where numbers were small, were used to determine statistical significance. Antenatal surveillance results were abnormal in 18% (10/56) of pregnancies carrying a fetus with high-risk CHD. There was a trend toward survival at last follow up when AS results were normal (72%, 33/46) compared to those in which surveillance results were abnormal (40%, 4/10), p 0.07. Where AS results were abnormal, significantly more had emergency caesarean sections for fetal indications (7/10 (70%), vs. 2/46 (4%), p < 0.001). IUFD occurred in 20% (2/10) of cases where AS results were abnormal, compared to 7% (3/46) of cases where surveillance results were normal, p 0.21. Where AS was infrequent, IUFD occurred in 13% (4/30), compared to 3% (1/31) where surveillance was frequent, p=0.20. A final CVPS of ≤7 carried a significantly higher mortality rate (11/21, 52%) than a score of ≥8 (6/31, 19%), p 0.01. CONCLUSION Abnormal AS results and/or a CVPS of ≤7 may identify compromised fetuses with high-risk cardiac lesions who could benefit from altered management or expedited delivery. Given the high rates of abnormal surveillance results in this population, frequent surveillance should be considered. A larger trial is warranted to establish whether this leads to a reduction in fetal demise. Certain congenital heart diseases (CHDs) are associated with a high risk of intrauterine fetal demise (IUFD) and post-natal death, including Ebstein's anomaly, tetralogy of Fallot with absent pulmonary valve and cardiomyopathy. Established obstetric guidelines that recommend frequent antenatal surveillance (AS) of fetal wellbeing in the case of specific maternal and fetal risk factors do not currently include fetuses with high-risk CHD. We sought to establish whether frequent antenatal surveillance could improve fetal outcomes in high-risk fetal CHD and if surveillance results are predictive of outcomes in this setting. We hypothesized that fetuses with high-risk cardiac lesions would benefit from frequent AS and that outcomes would be poorer where surveillance results were abnormal. We undertook a single center, retrospective review of 61 pregnancies with high-risk fetal CHD diagnosed from 2006-2020. Data pertaining to frequency and results of AS were collected. AS was conducted using the biophysical profile score, non-stress testing and/or fetal echocardiogram. Where possible, the cardiovascular profile score (CVPS) was calculated retrospectively. Frequent surveillance was defined as at least weekly fetal wellbeing testing commencing by 28-32 weeks gestation, or from later diagnosis, until delivery. Outcome measures included survival and mode of delivery. Chi-square testing, or Fisher's exact where numbers were small, were used to determine statistical significance. Antenatal surveillance results were abnormal in 18% (10/56) of pregnancies carrying a fetus with high-risk CHD. There was a trend toward survival at last follow up when AS results were normal (72%, 33/46) compared to those in which surveillance results were abnormal (40%, 4/10), p 0.07. Where AS results were abnormal, significantly more had emergency caesarean sections for fetal indications (7/10 (70%), vs. 2/46 (4%), p < 0.001). IUFD occurred in 20% (2/10) of cases where AS results were abnormal, compared to 7% (3/46) of cases where surveillance results were normal, p 0.21. Where AS was infrequent, IUFD occurred in 13% (4/30), compared to 3% (1/31) where surveillance was frequent, p=0.20. A final CVPS of ≤7 carried a significantly higher mortality rate (11/21, 52%) than a score of ≥8 (6/31, 19%), p 0.01. Abnormal AS results and/or a CVPS of ≤7 may identify compromised fetuses with high-risk cardiac lesions who could benefit from altered management or expedited delivery. Given the high rates of abnormal surveillance results in this population, frequent surveillance should be considered. A larger trial is warranted to establish whether this leads to a reduction in fetal demise." @default.
- W3207883979 created "2021-10-25" @default.
- W3207883979 creator A5016399488 @default.
- W3207883979 creator A5036637621 @default.
- W3207883979 creator A5037931651 @default.
- W3207883979 creator A5051983665 @default.
- W3207883979 creator A5058452902 @default.
- W3207883979 creator A5087023379 @default.
- W3207883979 date "2021-10-01" @default.
- W3207883979 modified "2023-09-27" @default.
- W3207883979 title "ANTENATAL SURVEILLANCE IN HIGH-RISK FETAL CARDIAC DISEASE: FREQUENCY, RESULTS AND RELATIONSHIP WITH SURVIVAL" @default.
- W3207883979 doi "https://doi.org/10.1016/j.cjca.2021.07.064" @default.
- W3207883979 hasPublicationYear "2021" @default.
- W3207883979 type Work @default.
- W3207883979 sameAs 3207883979 @default.
- W3207883979 citedByCount "0" @default.
- W3207883979 crossrefType "journal-article" @default.
- W3207883979 hasAuthorship W3207883979A5016399488 @default.
- W3207883979 hasAuthorship W3207883979A5036637621 @default.
- W3207883979 hasAuthorship W3207883979A5037931651 @default.
- W3207883979 hasAuthorship W3207883979A5051983665 @default.
- W3207883979 hasAuthorship W3207883979A5058452902 @default.
- W3207883979 hasAuthorship W3207883979A5087023379 @default.
- W3207883979 hasConcept C126322002 @default.
- W3207883979 hasConcept C131872663 @default.
- W3207883979 hasConcept C167135981 @default.
- W3207883979 hasConcept C172680121 @default.
- W3207883979 hasConcept C187212893 @default.
- W3207883979 hasConcept C2777162553 @default.
- W3207883979 hasConcept C2778258057 @default.
- W3207883979 hasConcept C2778646171 @default.
- W3207883979 hasConcept C2779234561 @default.
- W3207883979 hasConcept C2780074459 @default.
- W3207883979 hasConcept C54355233 @default.
- W3207883979 hasConcept C71924100 @default.
- W3207883979 hasConcept C86803240 @default.
- W3207883979 hasConceptScore W3207883979C126322002 @default.
- W3207883979 hasConceptScore W3207883979C131872663 @default.
- W3207883979 hasConceptScore W3207883979C167135981 @default.
- W3207883979 hasConceptScore W3207883979C172680121 @default.
- W3207883979 hasConceptScore W3207883979C187212893 @default.
- W3207883979 hasConceptScore W3207883979C2777162553 @default.
- W3207883979 hasConceptScore W3207883979C2778258057 @default.
- W3207883979 hasConceptScore W3207883979C2778646171 @default.
- W3207883979 hasConceptScore W3207883979C2779234561 @default.
- W3207883979 hasConceptScore W3207883979C2780074459 @default.
- W3207883979 hasConceptScore W3207883979C54355233 @default.
- W3207883979 hasConceptScore W3207883979C71924100 @default.
- W3207883979 hasConceptScore W3207883979C86803240 @default.
- W3207883979 hasIssue "10" @default.
- W3207883979 hasLocation W32078839791 @default.
- W3207883979 hasOpenAccess W3207883979 @default.
- W3207883979 hasPrimaryLocation W32078839791 @default.
- W3207883979 hasRelatedWork W1893469957 @default.
- W3207883979 hasRelatedWork W1969022859 @default.
- W3207883979 hasRelatedWork W1972872568 @default.
- W3207883979 hasRelatedWork W2041651589 @default.
- W3207883979 hasRelatedWork W2090194509 @default.
- W3207883979 hasRelatedWork W2368136628 @default.
- W3207883979 hasRelatedWork W2380419659 @default.
- W3207883979 hasRelatedWork W2391330661 @default.
- W3207883979 hasRelatedWork W4205863542 @default.
- W3207883979 hasRelatedWork W60557063 @default.
- W3207883979 hasVolume "37" @default.
- W3207883979 isParatext "false" @default.
- W3207883979 isRetracted "false" @default.
- W3207883979 magId "3207883979" @default.
- W3207883979 workType "article" @default.